Cue biopharma to present at the 2024 american society of clinical oncology (asco) annual meeting

Boston, april 24, 2024 (globe newswire) -- cue biopharma, inc. (nasdaq: cue), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific t cells, announced today that it will present an oral abstract and poster at the american society of clinical oncology (asco) annual meeting, taking place may 31 – june 4, 2024 in chicago, il.
CUE Ratings Summary
CUE Quant Ranking